Over the Counter (OTC) Drugs & Dietary Supplements Market by Category (Vitamin and Dietary Supplements, Cough & Cold Products, Analgesics, Gastrointestinal Products, Sleep Aids, Otic Products, Wart Removers, Mouth Care Products, Ophthalmic Products, Botanicals, Antacids, Smoking Cessation Products, Feminine Care, and Others), Dosage Form (Tablets, Hard Capsules, Powders, Ointments, Soft Capsules, Liquids, and Others), Product (Branded, and Generic Drugs), and Distribution Channel [Pharmacies, Grocery Stores, Vitamin and Health Food Stores, Online Pharmacies, and Others] - Global Opportunity Analysis and Industry Forecast, 2017-2023
Over the counter (OTC) drugs are non-prescription medicines, which are sold directly to consumers without any prescription from doctors and other healthcare professionals. The OTC drugs are regulated by governmental bodies to ensure that the ingredients used are safe and effective for use without a physician’s supervision. These drugs are regulated by active pharmaceutical ingredients (APIs) not final product. Dietary supplements are intended to provide nutrients to increase the quantity of consumption or provide non-nutrient chemicals that have biologically beneficial effects to users. These supplements are available across all distribution channels such as pharmacies, grocery stores, shopping marts, online pharmacies, and other retailers. The global over the counter (OTC) drugs & dietary supplements market was valued at $223 billion in 2016, and is expected to reach at $335 billion by 2023, registering a CAGR of 5.9% from 2017 to 2023.
The global over the counter (OTC) drugs & dietary supplements market is driven by improvement in lifestyle & ageing of baby boomers, rise in consumer awareness related to preventative healthcare, and proliferation of distribution channels. In addition, increase in trend of self-directed consumers and self-medication for the treatment of primary health conditions have fueled the market growth. However, stringent regulations by FDA and other governing bodies related to the safety & efficacy of OTC medications have delayed the approval restricting the market growth. Furthermore, minors, i.e. individuals under 18 years of age, are restricted to buy certain medications, which consist addictive chemicals, impeding the market growth.
The global over the counter (OTC) drugs & dietary supplements market is segmented based on category, dosage form, product, distribution channel, and geography. Based on category, it is divided into vitamin and dietary supplements, cough & cold products, analgesics, gastrointestinal products, sleep aids, otic products, wart removers, mouth care products, ophthalmic products, botanicals, antacids, smoking cessation products, feminine care, and others. On the basis of dosage form, it is classified into tablets, hard capsules, powders, ointments, soft capsules, liquids, and others. Based on product, it is categorized into branded and generic drugs. Based on distribution channel, it is divided into pharmacies, grocery stores, vitamin & health food stores, online pharmacies, and others.
Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the highest market share in 2016, and is expected to maintain its dominance throughout the forecast period. This is attributed to the high consumer base especially for dietary supplements as consumers are more health conscious. However, Asia-Pacific is expected to emerge as a lucrative area for market players, due to increase in disposable income along with a shift in the consumer preference towards self-medication, improvement in healthcare facilities, and rapid development of economic conditions.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the global over the counter (OTC) drugs & dietary supplements market along with current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analyses of factors that drive and restrict the market growth are provided in the report.
Comprehensive quantitative analysis of the industry from 2016 to 2023 is provided to enable stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps in understanding the trending products across the various regions.
Key market players and their strategies are provided to understand the competitive outlook of the industry.
KEY MARKET SEGMENTS
By Category
Vitamin & Dietary Supplements
Cough & Cold Products
Analgesics
Gastrointestinal Products
Sleep Aids
Otic Products
Wart Removers
Mouth Care Products
Ophthalmic Products
Botanicals
Antacids
Smoking Cessation Products
Feminine Care
Others
By Dosage Form
Tablets
Hard Capsules
Powders
Ointments
Soft Capsules
Liquids
Others
By Product
Branded Drugs
Generic Drugs
By Distribution Channel
Pharmacies
Grocery Stores
Vitamin & Health Food Stores
Online Pharmacy
Others
By Geography
North America
U.S.
Canada
Mexico
Europe
U.K.
France
Germany
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Argentina
Turkey
South Africa
Saudi Arabia
Rest of LAMEA
KEY PLAYERS PROFILED
Pfizer Inc.
Novartis International AG.
Roche Holding AG
Merck & Co., Inc.
Sanofi S.A
Johnson & Johnson
Gilead Sciences
GlaxoSmithKline plc.
Bayer Healthcare AG
AstraZeneca plc.
The other players in the value chain include (profiles not included in the report)
Alacer Corp
Alcon Inc.
Alfresa Pharma Corporation
Alkalon A/S
Alliance Healthcare
Allergan, Plc.
Reckitt Benckiser Plc.
Bausch & Lomb
AbbVie Inc.
The Colgate-Palmolive Company
The global over the counter (OTC) drugs & dietary supplements market is driven by improvement in lifestyle & ageing of baby boomers, rise in consumer awareness related to preventative healthcare, and proliferation of distribution channels. In addition, increase in trend of self-directed consumers and self-medication for the treatment of primary health conditions have fueled the market growth. However, stringent regulations by FDA and other governing bodies related to the safety & efficacy of OTC medications have delayed the approval restricting the market growth. Furthermore, minors, i.e. individuals under 18 years of age, are restricted to buy certain medications, which consist addictive chemicals, impeding the market growth.
The global over the counter (OTC) drugs & dietary supplements market is segmented based on category, dosage form, product, distribution channel, and geography. Based on category, it is divided into vitamin and dietary supplements, cough & cold products, analgesics, gastrointestinal products, sleep aids, otic products, wart removers, mouth care products, ophthalmic products, botanicals, antacids, smoking cessation products, feminine care, and others. On the basis of dosage form, it is classified into tablets, hard capsules, powders, ointments, soft capsules, liquids, and others. Based on product, it is categorized into branded and generic drugs. Based on distribution channel, it is divided into pharmacies, grocery stores, vitamin & health food stores, online pharmacies, and others.
Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the highest market share in 2016, and is expected to maintain its dominance throughout the forecast period. This is attributed to the high consumer base especially for dietary supplements as consumers are more health conscious. However, Asia-Pacific is expected to emerge as a lucrative area for market players, due to increase in disposable income along with a shift in the consumer preference towards self-medication, improvement in healthcare facilities, and rapid development of economic conditions.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the global over the counter (OTC) drugs & dietary supplements market along with current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analyses of factors that drive and restrict the market growth are provided in the report.
Comprehensive quantitative analysis of the industry from 2016 to 2023 is provided to enable stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps in understanding the trending products across the various regions.
Key market players and their strategies are provided to understand the competitive outlook of the industry.
KEY MARKET SEGMENTS
By Category
Vitamin & Dietary Supplements
Cough & Cold Products
Analgesics
Gastrointestinal Products
Sleep Aids
Otic Products
Wart Removers
Mouth Care Products
Ophthalmic Products
Botanicals
Antacids
Smoking Cessation Products
Feminine Care
Others
By Dosage Form
Tablets
Hard Capsules
Powders
Ointments
Soft Capsules
Liquids
Others
By Product
Branded Drugs
Generic Drugs
By Distribution Channel
Pharmacies
Grocery Stores
Vitamin & Health Food Stores
Online Pharmacy
Others
By Geography
North America
U.S.
Canada
Mexico
Europe
U.K.
France
Germany
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Argentina
Turkey
South Africa
Saudi Arabia
Rest of LAMEA
KEY PLAYERS PROFILED
Pfizer Inc.
Novartis International AG.
Roche Holding AG
Merck & Co., Inc.
Sanofi S.A
Johnson & Johnson
Gilead Sciences
GlaxoSmithKline plc.
Bayer Healthcare AG
AstraZeneca plc.
The other players in the value chain include (profiles not included in the report)
Alacer Corp
Alcon Inc.
Alfresa Pharma Corporation
Alkalon A/S
Alliance Healthcare
Allergan, Plc.
Reckitt Benckiser Plc.
Bausch & Lomb
AbbVie Inc.
The Colgate-Palmolive Company
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTERS FIVE FORCES ANALYSIS
3.4. REGULATORY FRAMEWORK
3.5. MARKET SHARE ANALYSIS, 2016
3.6. MARKET DYNAMICS
3.6.1. Drivers
3.6.1.1. Improvement in lifestyle and age related diseases
3.6.1.2. The rise in self-directed consumer
3.6.1.3. Growing awareness regarding general health concerns and advancements in healthcare industry
3.6.2. Restraints
3.6.2.1. Stringent regulatory policies by governing bodies
3.6.2.2. Lack of seamless reclassification of drugs from prescription medicines to over the counter drugs
3.6.3. Opportunities
3.6.3.1. Increasing R&D expenditure and funding from the public & private sector
CHAPTER 4 OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY CATEGORIES
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. VITAMIN AND DIETARY SUPPLEMENTS (VDS)
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. COUGH & COLD PRODUCTS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. ANALGESICS
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.5. GASTROINTESTINAL PRODUCTS
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
4.6. SLEEP AIDS
4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast
4.7. OTIC PRODUCTS
4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast
4.8. WART REMOVERS
4.8.1. Key market trends
4.8.2. Growth factors and opportunities
4.8.3. Market size and forecast
4.9. MOUTH CARE PRODUCTS
4.9.1. Key market trends
4.9.2. Growth factors and opportunities
4.9.3. Market size and forecast
4.10. OPHTHALMIC PRODUCTS
4.10.1. Key market trends
4.10.2. Growth factors and opportunities
4.10.3. Market size and forecast
4.11. BOTANICALS
4.11.1. Key market trends
4.11.2. Growth factors and opportunities
4.11.3. Market size and forecast
4.12. ANTACIDS
4.12.1. Key market trends
4.12.2. Growth factors and opportunities
4.12.3. Market size and forecast
4.13. SMOKING CESSATION PRODUCTS
4.13.1. Key market trends
4.13.2. Growth factors and opportunities
4.13.3. Market size and forecast
4.14. FEMININE CARE
4.14.1. Key market trends
4.14.2. Growth factors and opportunities
4.14.3. Market size and forecast
4.15. OTHERS
4.15.1. Key market trends
4.15.2. Growth factors and opportunities
4.15.3. Market size and forecast
CHAPTER 5 OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DOSAGE FORMS
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. TABLETS
5.2.1. Market size and forecast
5.3. HARD CAPSULES
5.3.1. Market size and forecast
5.4. POWDERS
5.4.1. Market size and forecast
5.5. OINTMENTS
5.5.1. Market size and forecast
5.6. SOFT CAPSULES
5.6.1. Market size and forecast
5.7. LIQUIDS
5.7.1. Market size and forecast
5.8. OTHERS
5.8.1. Market size and forecast
CHAPTER 6 OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS, BY PRODUCT TYPE
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. BRANDED
6.2.1. Market size and forecast
6.3. GENERICS
6.3.1. Market size and forecast
CHAPTER 7 OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. PHARMACIES
7.2.1. Market size and forecast
7.3. VITAMIN AND HEALTH FOOD STORES
7.3.1. Market size and forecast
7.4. ONLINE PHARMACY
7.4.1. Market size and forecast
7.5. GROCERY STORES
7.5.1. Market size and forecast
7.6. OTHERS
7.6.1. Market size and forecast
CHAPTER 8 OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY GEOGRAPHY
8.1. OVERVIEW
8.1.1. Market size and forecast
8.2. NORTH AMERICA
8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast
8.2.3.1. U.S. market size and forecast
8.2.3.2. Mexico market size and forecast
8.2.3.3. Canada market size and forecast
8.3. EUROPE
8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast
8.3.3.1. UK market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. Germany market size and forecast
8.3.3.4. Italy market size and forecast
8.3.3.5. Spain market size and forecast
8.3.3.6. Rest of Europe market size and forecast
8.4. ASIA-PACIFIC
8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast
8.4.3.1. Japan market size and forecast
8.4.3.2. China market size and forecast
8.4.3.3. India market size and forecast
8.4.3.4. Australia market size and forecast
8.4.3.5. Rest of Asia-Pacific market size and forecast
8.5. LAMEA
8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast
8.5.3.1. Brazil market size and forecast
8.5.3.2. Argentina market size and forecast
8.5.3.3. Turkey market size and forecast
8.5.3.4. Saudi Arabia market size and forecast
8.5.3.5. South Africa market size and forecast
8.5.3.6. Rest of LAMEA market size and forecast
CHAPTER 9 COMPANY PROFILES
9.1. PFIZER INC.
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Business performance
9.1.5. Key strategic moves and developments
9.2. NOVARTIS INTERNATIONAL AG
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Business performance
9.2.5. Key strategic moves and developments
9.3. ROCHE HOLDING AG
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Business performance
9.3.5. Key strategic moves and developments
9.4. MERCK & CO., INC.
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Business performance
9.4.5. Key strategic moves and developments
9.5. SANOFI S.A
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Business performance
9.5.5. Key strategic moves and developments
9.6. JOHNSON & JOHNSON
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Business performance
9.6.5. Key strategic moves and developments
9.7. GILEAD SCIENCES
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Business performance
9.7.5. Key strategic moves and developments
9.8. GLAXOSMITHKLINE PLC
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Business performance
9.8.5. Key strategic moves and developments
9.9. BAYER HEALTHCARE AG
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Business performance
9.9.5. Key strategic moves and developments
9.10. ASTRAZENECA PLC
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Business performance
9.10.5. Key strategic moves and developments
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTERS FIVE FORCES ANALYSIS
3.4. REGULATORY FRAMEWORK
3.5. MARKET SHARE ANALYSIS, 2016
3.6. MARKET DYNAMICS
3.6.1. Drivers
3.6.1.1. Improvement in lifestyle and age related diseases
3.6.1.2. The rise in self-directed consumer
3.6.1.3. Growing awareness regarding general health concerns and advancements in healthcare industry
3.6.2. Restraints
3.6.2.1. Stringent regulatory policies by governing bodies
3.6.2.2. Lack of seamless reclassification of drugs from prescription medicines to over the counter drugs
3.6.3. Opportunities
3.6.3.1. Increasing R&D expenditure and funding from the public & private sector
CHAPTER 4 OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY CATEGORIES
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. VITAMIN AND DIETARY SUPPLEMENTS (VDS)
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. COUGH & COLD PRODUCTS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. ANALGESICS
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.5. GASTROINTESTINAL PRODUCTS
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
4.6. SLEEP AIDS
4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast
4.7. OTIC PRODUCTS
4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast
4.8. WART REMOVERS
4.8.1. Key market trends
4.8.2. Growth factors and opportunities
4.8.3. Market size and forecast
4.9. MOUTH CARE PRODUCTS
4.9.1. Key market trends
4.9.2. Growth factors and opportunities
4.9.3. Market size and forecast
4.10. OPHTHALMIC PRODUCTS
4.10.1. Key market trends
4.10.2. Growth factors and opportunities
4.10.3. Market size and forecast
4.11. BOTANICALS
4.11.1. Key market trends
4.11.2. Growth factors and opportunities
4.11.3. Market size and forecast
4.12. ANTACIDS
4.12.1. Key market trends
4.12.2. Growth factors and opportunities
4.12.3. Market size and forecast
4.13. SMOKING CESSATION PRODUCTS
4.13.1. Key market trends
4.13.2. Growth factors and opportunities
4.13.3. Market size and forecast
4.14. FEMININE CARE
4.14.1. Key market trends
4.14.2. Growth factors and opportunities
4.14.3. Market size and forecast
4.15. OTHERS
4.15.1. Key market trends
4.15.2. Growth factors and opportunities
4.15.3. Market size and forecast
CHAPTER 5 OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DOSAGE FORMS
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. TABLETS
5.2.1. Market size and forecast
5.3. HARD CAPSULES
5.3.1. Market size and forecast
5.4. POWDERS
5.4.1. Market size and forecast
5.5. OINTMENTS
5.5.1. Market size and forecast
5.6. SOFT CAPSULES
5.6.1. Market size and forecast
5.7. LIQUIDS
5.7.1. Market size and forecast
5.8. OTHERS
5.8.1. Market size and forecast
CHAPTER 6 OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS, BY PRODUCT TYPE
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. BRANDED
6.2.1. Market size and forecast
6.3. GENERICS
6.3.1. Market size and forecast
CHAPTER 7 OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. PHARMACIES
7.2.1. Market size and forecast
7.3. VITAMIN AND HEALTH FOOD STORES
7.3.1. Market size and forecast
7.4. ONLINE PHARMACY
7.4.1. Market size and forecast
7.5. GROCERY STORES
7.5.1. Market size and forecast
7.6. OTHERS
7.6.1. Market size and forecast
CHAPTER 8 OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY GEOGRAPHY
8.1. OVERVIEW
8.1.1. Market size and forecast
8.2. NORTH AMERICA
8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast
8.2.3.1. U.S. market size and forecast
8.2.3.2. Mexico market size and forecast
8.2.3.3. Canada market size and forecast
8.3. EUROPE
8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast
8.3.3.1. UK market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. Germany market size and forecast
8.3.3.4. Italy market size and forecast
8.3.3.5. Spain market size and forecast
8.3.3.6. Rest of Europe market size and forecast
8.4. ASIA-PACIFIC
8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast
8.4.3.1. Japan market size and forecast
8.4.3.2. China market size and forecast
8.4.3.3. India market size and forecast
8.4.3.4. Australia market size and forecast
8.4.3.5. Rest of Asia-Pacific market size and forecast
8.5. LAMEA
8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast
8.5.3.1. Brazil market size and forecast
8.5.3.2. Argentina market size and forecast
8.5.3.3. Turkey market size and forecast
8.5.3.4. Saudi Arabia market size and forecast
8.5.3.5. South Africa market size and forecast
8.5.3.6. Rest of LAMEA market size and forecast
CHAPTER 9 COMPANY PROFILES
9.1. PFIZER INC.
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Business performance
9.1.5. Key strategic moves and developments
9.2. NOVARTIS INTERNATIONAL AG
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Business performance
9.2.5. Key strategic moves and developments
9.3. ROCHE HOLDING AG
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Business performance
9.3.5. Key strategic moves and developments
9.4. MERCK & CO., INC.
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Business performance
9.4.5. Key strategic moves and developments
9.5. SANOFI S.A
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Business performance
9.5.5. Key strategic moves and developments
9.6. JOHNSON & JOHNSON
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Business performance
9.6.5. Key strategic moves and developments
9.7. GILEAD SCIENCES
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Business performance
9.7.5. Key strategic moves and developments
9.8. GLAXOSMITHKLINE PLC
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Business performance
9.8.5. Key strategic moves and developments
9.9. BAYER HEALTHCARE AG
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Business performance
9.9.5. Key strategic moves and developments
9.10. ASTRAZENECA PLC
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Business performance
9.10.5. Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY CATEGORIES, 2016-2023 ($MILLION)
TABLE 2. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR VITAMIN AND DIETARY SUPPLEMENTS, BY REGION, 2016-2023 ($MILLION)
TABLE 3. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR COUGH AND COLD PRODUCTS, BY REGION, 2016-2023 ($MILLION)
TABLE 4. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR ANALGESICS, BY REGION, 2016-2023 ($MILLION)
TABLE 5. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR GASTROINTESTINAL PRODUCTS, BY REGION, 2016-2023 ($MILLION)
TABLE 6. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR SLEEP AIDS, BY REGION, 2016-2023 ($MILLION)
TABLE 7. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR OTIC PRODUCTS, BY REGION, 2016-2023 ($MILLION)
TABLE 8. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR WART REMOVERS, BY REGION, 2016-2023 ($MILLION)
TABLE 9. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR MOUTH CARE PRODUCTS, BY REGION, 2016-2023 ($MILLION)
TABLE 10. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR OPHTHALMIC PRODUCTS, BY REGION, 2016-2023 ($MILLION)
TABLE 11. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR BOTANICALS, BY REGION, 2016-2023 ($MILLION)
TABLE 12. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR ANTACIDS, BY REGION, 2016-2023 ($MILLION)
TABLE 13. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR SMOKING CESSATION PRODUCTS, BY REGION, 2016-2023 ($MILLION)
TABLE 14. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR FEMININE CARE, BY REGION, 2016-2023 ($MILLION)
TABLE 15. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR OTHER CATEGORIES, BY REGION, 2016-2023 ($MILLION)
TABLE 16. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DOSAGE FORMS, 2016-2023 ($MILLION)
TABLE 17. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR TABLETS, BY REGION, 2016-2023 ($MILLION)
TABLE 18. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR HARD CAPSULES, BY REGION, 2016-2023 ($MILLION)
TABLE 19. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR POWDERS, BY REGION, 2016-2023 ($MILLION)
TABLE 20. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR OINTMENTS, BY REGION, 2016-2023 ($MILLION)
TABLE 21. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR SOFT CAPSULES, BY REGION, 2016-2023 ($MILLION)
TABLE 22. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR LIQUIDS, BY REGION, 2016-2023 ($MILLION)
TABLE 23. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR OTHER DOSAGE FORMS, BY REGION, 2016-2023 ($MILLION)
TABLE 24. GLOBAL OVER THE COUNTER DRUGS AND DIETARY SUPPLEMENTS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 25. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR BRANDED DRUGS, BY REGION, 2016-2023 ($MILLION)
TABLE 26. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR GENERIC DRUGS, BY REGION, 2016-2023 ($MILLION)
TABLE 27. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 28. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR PHARMACIES, BY REGION, 2016-2023 ($MILLION)
TABLE 29. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR VITAMIN AND HEALTH FOOD STORES, BY REGION, 2016-2023 ($MILLION)
TABLE 30. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR ONLINE PHARMACY, BY REGION, 2016-2023 ($MILLION)
TABLE 31. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR GROCERY STORES, BY REGION, 2016-2023 ($MILLION)
TABLE 32. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR OTHER DISTRIBUTION CHANNELS, BY REGION, 2016-2023 ($MILLION)
TABLE 33. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 34. NORTH AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 35. NORTH AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY CATEGORIES, 2016-2023 ($MILLION)
TABLE 36. NORTH AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DOSAGE FORMS, 2016-2023 ($MILLION)
TABLE 37. NORTH AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 38. NORTH AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY END USE, 2016-2023 ($MILLION)
TABLE 39. EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 40. EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY CATEGORIES, 2016-2023 ($MILLION)
TABLE 41. EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DOSAGE FORMS, 2016-2023 ($MILLION)
TABLE 42. EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 43. EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 44. ASIA-PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 45. ASIA-PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY CATEGORIES, 2016-2023 ($MILLION)
TABLE 46. ASIA-PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DOSAGE FORMS, 2016-2023 ($MILLION)
TABLE 47. ASIA-PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 48. ASIA-PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 49. LAMEA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 50. LAMEA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY CATEGORIES, 2016-2023 ($MILLION)
TABLE 51. LAMEA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DOSAGE FORMS, 2016-2023 ($MILLION)
TABLE 52. LAMEA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 53. LAMEA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 54. PFIZER: COMPANY SNAPSHOT
TABLE 55. PFIZER: OPERATING SEGMENTS
TABLE 56. NOVARTIS: COMPANY SNAPSHOT
TABLE 57. NOVARTIS: OPERATING SEGMENTS
TABLE 58. ROCHE: COMPANY SNAPSHOT
TABLE 59. ROCHE: OPERATING SEGMENTS
TABLE 60. MERCK: COMPANY SNAPSHOT
TABLE 61. MERCK: OPERATING SEGMENTS
TABLE 62. SANOFI: COMPANY SNAPSHOT
TABLE 63. SANOFI: OPERATING SEGMENTS
TABLE 64. JOHNSON: COMPANY SNAPSHOT
TABLE 65. JOHNSON: OPERATING SEGMENTS
TABLE 66. GILEAD: COMPANY SNAPSHOT
TABLE 67. GILEAD: OPERATING SEGMENTS
TABLE 68. GSK: COMPANY SNAPSHOT
TABLE 69. GSK: OPERATING SEGMENTS
TABLE 70. BAYER: COMPANY SNAPSHOT
TABLE 71. BAYER: OPERATING SEGMENTS
TABLE 72. ASTRAZENECA: COMPANY SNAPSHOT
TABLE 73. ASTRAZENECA: OPERATING SEGMENTS
TABLE 1. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY CATEGORIES, 2016-2023 ($MILLION)
TABLE 2. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR VITAMIN AND DIETARY SUPPLEMENTS, BY REGION, 2016-2023 ($MILLION)
TABLE 3. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR COUGH AND COLD PRODUCTS, BY REGION, 2016-2023 ($MILLION)
TABLE 4. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR ANALGESICS, BY REGION, 2016-2023 ($MILLION)
TABLE 5. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR GASTROINTESTINAL PRODUCTS, BY REGION, 2016-2023 ($MILLION)
TABLE 6. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR SLEEP AIDS, BY REGION, 2016-2023 ($MILLION)
TABLE 7. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR OTIC PRODUCTS, BY REGION, 2016-2023 ($MILLION)
TABLE 8. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR WART REMOVERS, BY REGION, 2016-2023 ($MILLION)
TABLE 9. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR MOUTH CARE PRODUCTS, BY REGION, 2016-2023 ($MILLION)
TABLE 10. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR OPHTHALMIC PRODUCTS, BY REGION, 2016-2023 ($MILLION)
TABLE 11. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR BOTANICALS, BY REGION, 2016-2023 ($MILLION)
TABLE 12. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR ANTACIDS, BY REGION, 2016-2023 ($MILLION)
TABLE 13. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR SMOKING CESSATION PRODUCTS, BY REGION, 2016-2023 ($MILLION)
TABLE 14. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR FEMININE CARE, BY REGION, 2016-2023 ($MILLION)
TABLE 15. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR OTHER CATEGORIES, BY REGION, 2016-2023 ($MILLION)
TABLE 16. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DOSAGE FORMS, 2016-2023 ($MILLION)
TABLE 17. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR TABLETS, BY REGION, 2016-2023 ($MILLION)
TABLE 18. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR HARD CAPSULES, BY REGION, 2016-2023 ($MILLION)
TABLE 19. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR POWDERS, BY REGION, 2016-2023 ($MILLION)
TABLE 20. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR OINTMENTS, BY REGION, 2016-2023 ($MILLION)
TABLE 21. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR SOFT CAPSULES, BY REGION, 2016-2023 ($MILLION)
TABLE 22. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR LIQUIDS, BY REGION, 2016-2023 ($MILLION)
TABLE 23. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR OTHER DOSAGE FORMS, BY REGION, 2016-2023 ($MILLION)
TABLE 24. GLOBAL OVER THE COUNTER DRUGS AND DIETARY SUPPLEMENTS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 25. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR BRANDED DRUGS, BY REGION, 2016-2023 ($MILLION)
TABLE 26. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR GENERIC DRUGS, BY REGION, 2016-2023 ($MILLION)
TABLE 27. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 28. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR PHARMACIES, BY REGION, 2016-2023 ($MILLION)
TABLE 29. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR VITAMIN AND HEALTH FOOD STORES, BY REGION, 2016-2023 ($MILLION)
TABLE 30. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR ONLINE PHARMACY, BY REGION, 2016-2023 ($MILLION)
TABLE 31. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR GROCERY STORES, BY REGION, 2016-2023 ($MILLION)
TABLE 32. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET FOR OTHER DISTRIBUTION CHANNELS, BY REGION, 2016-2023 ($MILLION)
TABLE 33. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 34. NORTH AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 35. NORTH AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY CATEGORIES, 2016-2023 ($MILLION)
TABLE 36. NORTH AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DOSAGE FORMS, 2016-2023 ($MILLION)
TABLE 37. NORTH AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 38. NORTH AMERICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY END USE, 2016-2023 ($MILLION)
TABLE 39. EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 40. EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY CATEGORIES, 2016-2023 ($MILLION)
TABLE 41. EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DOSAGE FORMS, 2016-2023 ($MILLION)
TABLE 42. EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 43. EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 44. ASIA-PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 45. ASIA-PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY CATEGORIES, 2016-2023 ($MILLION)
TABLE 46. ASIA-PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DOSAGE FORMS, 2016-2023 ($MILLION)
TABLE 47. ASIA-PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 48. ASIA-PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 49. LAMEA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 50. LAMEA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY CATEGORIES, 2016-2023 ($MILLION)
TABLE 51. LAMEA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DOSAGE FORMS, 2016-2023 ($MILLION)
TABLE 52. LAMEA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 53. LAMEA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL, 2016-2023 ($MILLION)
TABLE 54. PFIZER: COMPANY SNAPSHOT
TABLE 55. PFIZER: OPERATING SEGMENTS
TABLE 56. NOVARTIS: COMPANY SNAPSHOT
TABLE 57. NOVARTIS: OPERATING SEGMENTS
TABLE 58. ROCHE: COMPANY SNAPSHOT
TABLE 59. ROCHE: OPERATING SEGMENTS
TABLE 60. MERCK: COMPANY SNAPSHOT
TABLE 61. MERCK: OPERATING SEGMENTS
TABLE 62. SANOFI: COMPANY SNAPSHOT
TABLE 63. SANOFI: OPERATING SEGMENTS
TABLE 64. JOHNSON: COMPANY SNAPSHOT
TABLE 65. JOHNSON: OPERATING SEGMENTS
TABLE 66. GILEAD: COMPANY SNAPSHOT
TABLE 67. GILEAD: OPERATING SEGMENTS
TABLE 68. GSK: COMPANY SNAPSHOT
TABLE 69. GSK: OPERATING SEGMENTS
TABLE 70. BAYER: COMPANY SNAPSHOT
TABLE 71. BAYER: OPERATING SEGMENTS
TABLE 72. ASTRAZENECA: COMPANY SNAPSHOT
TABLE 73. ASTRAZENECA: OPERATING SEGMENTS
LIST OF FIGURES
FIGURE 1. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023
FIGURE 2. SEGMENTATION OF OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET
FIGURE 3. TOP INVESTMENT POCKETS IN GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET
FIGURE 4. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2016)
FIGURE 5. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 6. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 7. BARGAINING POWER OF BUYERS
FIGURE 8. BARGAINING POWER OF SUPPLIERS
FIGURE 9. THREAT OF NEW ENTRANTS
FIGURE 10. THREAT OF SUBSTITUTION
FIGURE 11. COMPETITIVE RIVALRY
FIGURE 12. RESTRAINTS AND DRIVERS: GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET
FIGURE 13. U.S. OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 14. MEXICO OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 15. CANADA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 16. UK OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 17. FRANCE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 18. GERMANY OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 19. ITALY OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 20. SPAIN OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 21. REST OF EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 22. JAPAN OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 23. CHINA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 24. INDIA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 25. AUSTRALIA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 26. REST OF ASIA-PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 27. BRAZIL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 28. ARGENTINA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 29. TURKEY OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 30. SAUDI ARABIA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 31. SOUTH AFRICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 32. REST OF LAMEA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 33. PFIZER: NET SALES, 2014-2016 ($MILLION)
FIGURE 34. PFIZER: REVENUE BY SEGMENT, 2016 (%)
FIGURE 35. PFIZER: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 36. NOVARTIS: NET SALES, 2014-2016 ($MILLION)
FIGURE 37. NOVARTIS: REVENUE BY SEGMENT, 2016 (%)
FIGURE 38. NOVARTIS: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 39. ROCHE: NET SALES, 2014-2016 ($MILLION)
FIGURE 40. ROCHE: REVENUE BY SEGMENT, 2016 (%)
FIGURE 41. ROCHE: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 42. MERCK: NET SALES, 2014-2016 ($MILLION)
FIGURE 43. MERCK: REVENUE BY SEGMENT, 2016 (%)
FIGURE 44. MERCK: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 45. SANOFI: NET SALES, 2014-2016 ($MILLION)
FIGURE 46. SANOFI: REVENUE BY SEGMENT, 2016 (%)
FIGURE 47. SANOFI: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 48. JOHNSON: NET SALES, 2014-2016 ($MILLION)
FIGURE 49. JOHNSON: REVENUE BY SEGMENT, 2016 (%)
FIGURE 50. JOHNSON: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 51. GILEAD: NET SALES, 2014-2016 ($MILLION)
FIGURE 52. GILEAD: REVENUE BY SEGMENT, 2016 (%)
FIGURE 53. GILEAD: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 54. GSK: NET SALES, 2014-2016 ($MILLION)
FIGURE 55. GSK: REVENUE BY SEGMENT, 2016 (%)
FIGURE 56. GSK: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 57. BAYER: NET SALES, 2014-2016 ($MILLION)
FIGURE 58. BAYER: REVENUE BY SEGMENT, 2016 (%)
FIGURE 59. BAYER: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 60. ASTRAZENECA: NET SALES, 2014-2016 ($MILLION)
FIGURE 61. ASTRAZENECA: REVENUE BY SEGMENT, 2016 (%)
FIGURE 62. ASTRAZENECA: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 1. GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023
FIGURE 2. SEGMENTATION OF OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET
FIGURE 3. TOP INVESTMENT POCKETS IN GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET
FIGURE 4. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2016)
FIGURE 5. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 6. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 7. BARGAINING POWER OF BUYERS
FIGURE 8. BARGAINING POWER OF SUPPLIERS
FIGURE 9. THREAT OF NEW ENTRANTS
FIGURE 10. THREAT OF SUBSTITUTION
FIGURE 11. COMPETITIVE RIVALRY
FIGURE 12. RESTRAINTS AND DRIVERS: GLOBAL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET
FIGURE 13. U.S. OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 14. MEXICO OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 15. CANADA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 16. UK OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 17. FRANCE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 18. GERMANY OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 19. ITALY OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 20. SPAIN OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 21. REST OF EUROPE OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 22. JAPAN OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 23. CHINA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 24. INDIA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 25. AUSTRALIA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 26. REST OF ASIA-PACIFIC OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 27. BRAZIL OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 28. ARGENTINA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 29. TURKEY OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 30. SAUDI ARABIA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 31. SOUTH AFRICA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 32. REST OF LAMEA OVER THE COUNTER (OTC) DRUGS AND DIETARY SUPPLEMENTS MARKET, 2016-2023 ($MILLION)
FIGURE 33. PFIZER: NET SALES, 2014-2016 ($MILLION)
FIGURE 34. PFIZER: REVENUE BY SEGMENT, 2016 (%)
FIGURE 35. PFIZER: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 36. NOVARTIS: NET SALES, 2014-2016 ($MILLION)
FIGURE 37. NOVARTIS: REVENUE BY SEGMENT, 2016 (%)
FIGURE 38. NOVARTIS: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 39. ROCHE: NET SALES, 2014-2016 ($MILLION)
FIGURE 40. ROCHE: REVENUE BY SEGMENT, 2016 (%)
FIGURE 41. ROCHE: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 42. MERCK: NET SALES, 2014-2016 ($MILLION)
FIGURE 43. MERCK: REVENUE BY SEGMENT, 2016 (%)
FIGURE 44. MERCK: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 45. SANOFI: NET SALES, 2014-2016 ($MILLION)
FIGURE 46. SANOFI: REVENUE BY SEGMENT, 2016 (%)
FIGURE 47. SANOFI: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 48. JOHNSON: NET SALES, 2014-2016 ($MILLION)
FIGURE 49. JOHNSON: REVENUE BY SEGMENT, 2016 (%)
FIGURE 50. JOHNSON: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 51. GILEAD: NET SALES, 2014-2016 ($MILLION)
FIGURE 52. GILEAD: REVENUE BY SEGMENT, 2016 (%)
FIGURE 53. GILEAD: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 54. GSK: NET SALES, 2014-2016 ($MILLION)
FIGURE 55. GSK: REVENUE BY SEGMENT, 2016 (%)
FIGURE 56. GSK: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 57. BAYER: NET SALES, 2014-2016 ($MILLION)
FIGURE 58. BAYER: REVENUE BY SEGMENT, 2016 (%)
FIGURE 59. BAYER: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 60. ASTRAZENECA: NET SALES, 2014-2016 ($MILLION)
FIGURE 61. ASTRAZENECA: REVENUE BY SEGMENT, 2016 (%)
FIGURE 62. ASTRAZENECA: REVENUE BY GEOGRAPHY, 2016 (%)
